Victoria Osborne
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 393 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,398 and has fallen 53.4% since, to $1,118 in 2023. Among family clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 393 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$839
- Novo Nordisk$712
- Lilly USA, LLC$571
- AstraZeneca$343
- Esperion Therapeutics, Inc.$334
- Novartis$314
- plus $3K from 28 others
What the payments were for
- Travel & lodging$200%
- Food & beverage$5,803100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 73 | $839 |
| Novo Nordisk | 67 | $712 |
| Lilly USA, LLC | 29 | $571 |
| AstraZeneca | 21 | $343 |
| Esperion Therapeutics, Inc. | 16 | $334 |
| Novartis | 19 | $314 |
| Amarin Pharma, Inc. | 16 | $305 |
| GSK | 19 | $296 |
| Merck | 18 | $264 |
| Bayer | 14 | $263 |
| Boehringer Ingelheim | 15 | $221 |
| Johnson & Johnson | 13 | $200 |
| Amgen | 13 | $166 |
| Kowa Pharmaceuticals America, Inc. | 8 | $154 |
| Otsuka America Pharmaceutical, Inc. | 7 | $110 |
| Sanofi-aventis U.S. LLC | 7 | $100 |
| Biogen | 5 | $83 |
| Mylan Specialty L.p. | 5 | $78 |
| Exact Sciences | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 3 | $47 |
| Pfizer | 3 | $47 |
| Corium, LLC | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Alkermes, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $28 |
| Acadia Pharmaceuticals Inc | 2 | $25 |
| UCB, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Aprecia Pharmaceuticals, LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$100
How this compares
$5,823 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 12 | $535 |
Paid to pharmacies, not to this prescriber.
Other family in Erwin
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.